Printer Friendly
Text Size
A A A
Skip Navigation
 

Funding

Skip Navigation LinksHome > Funding > Project Listing by Category

RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
12345
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Lung Cancer 2018 NCI NIH-18-017 South Carolina Research Foundation Support $700,000
Lung Cancer 2018 NIEHS 5R01ES022968-04 Induction of Neoplastic Transformation and Cancer Stem Cells by Carbon Nanotubes ROJANASAKUL, YON WEST VIRGINIA UNIVERSITY WV $335,250
Lung Cancer 2018 NCI 5R01CA194783-04 Computational modeling of tumor burden by CT to advance cancer therapeutics MAITLAND, MICHAEL INOVA HEALTH CARE SERVICES VA $573,026
Lung Cancer 2018 NIGMS 9R44GM130155-02 Interactive Digital Media to Support Children's Learning about Tobacco and the Human Body: "Dusty the Dragon" RAWITSCH, DON MOAI TECHNOLOGIES, LLC MN $894,755
Lung Cancer 2018 NCI 5R01CA201415-02 Longitudinal Study of Adolescent Tobacco Use and Tobacco Control Policy in India MISTRY, RITESH UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $543,849
Lung Cancer 2018 NCI 5F32CA200265-02 Hybrid Glycoproteomic and Autoantibody Biomarkers for Lung Cancer Early Detection LASTWIKA, KRISTIN FRED HUTCHINSON CANCER RESEARCH CENTER WA $60,278
Lung Cancer 2018 NIEHS 5R01ES005775-24 Hypoxia, DNA repair, and gene silencing GLAZER, PETER YALE UNIVERSITY CT $374,625
Lung Cancer 2018 NCI 5R01CA187392-03 Tumor-associated neutrophils in human lung cancer ERUSLANOV, EVGENIY UNIVERSITY OF PENNSYLVANIA PA $366,000
Lung Cancer 2018 NCI 5R01CA124495-11 Identification and targeting of the signaling pathways underlying lung cancer. KISSIL, JOSEPH SCRIPPS FLORIDA FL $432,000
Lung Cancer 2018 NCI 5R01CA184173-04 A Limited-angle Intra-fractional Verification (LIVE) System for SBRT Treatments REN, LEI DUKE UNIVERSITY NC $363,342
Lung Cancer 2018 NCI 1K22CA212045-01A1 Tumor Macroenvironment and the Circadian Metabolic Clock MASRI, SELMA UNIVERSITY OF CALIFORNIA-IRVINE CA $202,284
Lung Cancer 2018 NIGMS 5R01GM103790-03 Receptor and Carriers for Coupled Ion Transport SESSLER, JONATHAN UNIVERSITY OF TEXAS, AUSTIN TX $300,186
Lung Cancer 2018 NCI 5R01CA193583-03 Estrogen Signaling in a Mouse Model for Lymphangioleiomyomatosis HAMMES, STEPHEN UNIVERSITY OF ROCHESTER NY $352,275
Lung Cancer 2018 NCI 5R01CA136534-08 Structure-based anti-cancer drug development DENG, XINGMING EMORY UNIVERSITY GA $370,500
Lung Cancer 2018 NCI 5R01CA201049-03 Discovery and optimization of novel mutant-selective allosteric inhibitors of EGFR T790M ECK, MICHAEL DANA-FARBER CANCER INST MA $425,882
Lung Cancer 2018 NCI 5P30CA014089-43 8292 Cancer Control Research Program (Project-005) PENTZ, MARY ANN UNIVERSITY OF SOUTHERN CALIFORNIA CA $70,375
Lung Cancer 2018 NCI 5R01CA195227-03 Lead optimization of novel ML-IAP antagonists to treat lung cancer COSFORD, NICHOLAS SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $974,339
Lung Cancer 2018 NCI 5R01CA200900-03 Systemic RNA Delivery to Tumors SHI, JINJUN BRIGHAM AND WOMEN'S HOSPITAL MA $545,070
Lung Cancer 2018 NCI 5R01CA200999-04 Sex Hormones, Phytoestrogens and Lung Cancer in Female Nonsmokers YANG, GONG VANDERBILT UNIVERSITY MEDICAL CENTER TN $346,822
Lung Cancer 2018 NIMHD 5U01MD010648-03 Taxi STEP (Social networks, Technology, and Exercise through Pedometers) GANY, FRANCESCA SLOAN-KETTERING INST CAN RESEARCH NY $552,836
Lung Cancer 2018 NCI 5R01CA191489-04 A novel lineage pathway controls metabolic adaptation by metastatic lung cancers NGUYEN, DON YALE UNIVERSITY CT $380,278
Lung Cancer 2018 NCI 5R01CA211125-02 Regulation of lung cancer metastasis through transcriptional control of the Golgi apparatus KURIE, JONATHAN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $376,867
Lung Cancer 2018 NCI 5P30CA016058-42 5097 Cancer Control Research Program (CC) PASKETT, ELECTRA OHIO STATE UNIVERSITY OH $65,047
Lung Cancer 2018 NCI 5R01CA175691-05 Pathogenesis of Malignant Mesothelioma by the Human Polycomb Complex BAP1-ASXL TESTA, JOSEPH RESEARCH INST OF FOX CHASE CAN CTR PA $529,284
Lung Cancer 2018 NCI 5P30CA016086-42 8635 Cancer Prevention and Control Research Program (Program 8) RIBISL, KURT UNIV OF NORTH CAROLINA CHAPEL HILL NC $39,435
Lung Cancer 2018 NCI 5R01CA194027-03 Developing a pharmacologic approach to treat LKB1 mutant NSCLC patients MARCUS, ADAM EMORY UNIVERSITY GA $506,871
Lung Cancer 2018 NHLBI 5K08HL130666-04 The role of the long non-coding RNA Falcor in early endoderm and lung development SWARR, DANIEL, T (MD) CINCINNATI CHILDRENS HOSP MED CTR OH $162,540
Lung Cancer 2018 NCI 5R00CA197762-04 Investigating the role of the small GTPase RIT1 in lung adenocarcinoma BERGER, ALICE FRED HUTCHINSON CANCER RESEARCH CENTER WA $249,000
Lung Cancer 2018 NCI 5U01CA190234-04 Genotype and Imaging Phenotype Biomarkers in Lung Cancer AERTS, HUGO DANA-FARBER CANCER INST MA $659,886
Lung Cancer 2018 NCI 5R01CA207375-02 The Effectiveness, Safety, and Costs of Guideline-Concordant Lung Nodule Care FARJAH, FARHOOD UNIVERSITY OF WASHINGTON WA $621,132
Lung Cancer 2018 NCI 5R01CA207500-02 Mediastinal Lymph Node Identification in Lung Cancer using NIR Fluorescent VATS FRANGIONI, JOHN CURADEL, LLC MA $743,574
Lung Cancer 2018 NCI 5R03CA204825-02 Weight cycling and total and site-specific cancer incidence and mortality GIOVANNUCCI, EDWARD HARVARD SCHOOL OF PUBLIC HEALTH MA $79,500
Lung Cancer 2018 NCI 5R01CA200817-03 Clinical trial personalizing radiation therapy through a novel lung function imaging modality VINOGRADSKIY, YEVGENIY UNIVERSITY OF COLORADO DENVER CO $161,657
Lung Cancer 2018 NCI 5R01CA200905-02 Modulation of BAK in Lung Cancer Therapeutics DENG, XINGMING EMORY UNIVERSITY GA $356,850
Lung Cancer 2018 NCI 5R01CA200547-02 Investigating CREBBP as a tumor suppressor in small cell lung cancer MACPHERSON, DAVID FRED HUTCHINSON CANCER RESEARCH CENTER WA $441,962
Lung Cancer 2018 NCI 5R01CA213448-02 Immuno-PET imaging of high-grade neuroendocrine lung tumors using 89Zr-rovalpituzumab, a DLL3-targeting monoclonal antibody POIRIER, JOHN SLOAN-KETTERING INST CAN RESEARCH NY $699,927
Lung Cancer 2018 NCI 5P30CA014236-44 5327 Cancer Control and Population Sciences Research Program KASTAN, MICHAEL DUKE UNIVERSITY NC $25,546
Lung Cancer 2018 NCI 5P30CA023108-39 5366 Cancer Control (CC) SARGENT, JAMES DARTMOUTH COLLEGE NH $72,840
Lung Cancer 2018 NCI 5R01CA203636-02 Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment NISHINO, MIZUKI BRIGHAM AND WOMEN'S HOSPITAL MA $567,838
Lung Cancer 2018 NCI 5P30CA006516-53 5407 Program 13: Cancer Risk and Disparities VISWANATH, KASISOMAYAJULA DANA-FARBER CANCER INST MA $71,747
Lung Cancer 2018 NCI 5P30CA006516-53 5411 Program 34: Lung Cancer JOHNSON, BRUCE DANA-FARBER CANCER INST MA $72,325
Lung Cancer 2018 NIBIB 5R01EB020366-04 Next generation 4D-CBCT for lung cancer radiation therapy WANG, JING UT SOUTHWESTERN MEDICAL CENTER TX $364,500
Lung Cancer 2018 NIEHS 5R01ES016893-11 Particulate Cr(VI) Toxicology in Human Lung Epithelial Cells and Fibroblasts WISE, JOHN UNIVERSITY OF LOUISVILLE KY $350,832
Lung Cancer 2018 NCI 5R01CA091021-15 Tobacco Companies, Public Policy and Global Health LEE, KELLEY SIMON FRASER UNIVERSITY CANADA $95,386
Lung Cancer 2018 NCI 5P30CA008748-52 7574 Biostatistic THOMPSON, CRAIG SLOAN-KETTERING INST CAN RESEARCH NY $944,194
Lung Cancer 2018 NCI 5P30CA015704-43 5441 Research Program: Global Oncology CASPER, COREY FRED HUTCHINSON CANCER RESEARCH CENTER WA $87,209
Lung Cancer 2018 NCI 5R01CA204173-02 DNA damage signaling to immune checkpoints BAKKENIST, CHRISTOPHER UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $376,715
Lung Cancer 2018 NHLBI 5R01HL111190-06 REGULATION OF LUNG DEVELOPMENT BY FGF9 SIGNALING PATHWAYS ORNITZ, DAVID WASHINGTON UNIVERSITY MO $469,259
Lung Cancer 2018 NCI 5R01CA204264-02 A novel point of care test for oral and oropharyngeal cancer risk CALIFANO, JOSEPH UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $554,293
Lung Cancer 2018 NCI 5R01CA208403-02 A model for predicting response to PD-1 inhibitors in NSCLC GARON, EDWARD UNIVERSITY OF CALIFORNIA LOS ANGELES CA $635,258
Lung Cancer 2018 NIAAA 9R44AA027675-02 Smokescreen Translational (TL) Analysis Platform BAURLEY, JAMES BIOREALM CA $723,403
Lung Cancer 2018 NCI 5R01CA169102-06 Personalized Motion Management for truly 4D Lung Stereotactic Body Radiotherapy SAWANT, AMIT UNIVERSITY OF MARYLAND BALTIMORE MD $618,960
Lung Cancer 2018 NCI 5R01CA211052-02 Optimizing biologically-based rational polytherapy in ALK+ lung cancer BIVONA, TREVER UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $362,569
Lung Cancer 2018 NINR 5R01NR016694-02 Brief Behavioral Intervention for Dyspnea in Patients with Advanced Lung Cancer GREER, JOSEPH MASSACHUSETTS GENERAL HOSPITAL MA $499,749
Lung Cancer 2018 NCI 5R01CA201340-03 Defining Early Escape Strategies in LKB1 Mutant Lung Cancer MARCUS, ADAM EMORY UNIVERSITY GA $355,821
Lung Cancer 2018 NCI 5R01CA166480-07 MUC1-C Oncoprotein Evades Immune Destruction in Non-small Cell Lung Cancer KUFE, DONALD DANA-FARBER CANCER INST MA $636,708
Lung Cancer 2018 NCI 5F30CA213765-02 Determining the Mechanisms of TWIST1-mediated Crizotinib Resistance in MET-driven Non-Small Cell Lung Carcinoma YOCHUM, ZACHARY UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $49,524
Lung Cancer 2018 NCI 5R01CA205426-02 Elucidating genetics of response to immune checkpoint blockade in lung cancer RIZVI, NAIYER COLUMBIA UNIVERSITY HEALTH SCIENCES NY $558,644
Lung Cancer 2018 NIDA 5R01DA042738-02 Clean Indoor Air Laws, Cigarette Taxes, and Use of Smoking Cessation Treatments RUTKOW, HELAINE JOHNS HOPKINS UNIVERSITY MD $368,110
Lung Cancer 2018 NCI 5K07CA180782-05 The Cost-Effectiveness of Lung Cancer Screening in HIV Infection SIGEL, KEITH ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $101,520
Lung Cancer 2018 NIEHS 5R01ES022935-05 SATB2 and Nickel Carcingenesis COSTA, MAX NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $422,779
Lung Cancer 2018 NIEHS 5R01ES025515-04 Oxidative stress, Cr(VI) carcinogenesis, and prevention SHI, XIANGLIN UNIVERSITY OF KENTUCKY KY $728,875
Lung Cancer 2018 NCI 5R01CA204004-02 Use of Alternative Tobacco Products Among Homeless Youth TUCKER, JOAN RAND CORPORATION CA $291,072
Lung Cancer 2018 NCI 5P30CA062203-21 4041 Cancer Prevention, Outcomes and Survivorship Program (CPOS) WENZEL, LARI UNIVERSITY OF CALIFORNIA-IRVINE CA $28,545
Lung Cancer 2018 NCI 2P01CA129243-11 5313 Project 1: Mediators of Lung Adenocarcinoma Metastatis MASSAGUE, JOAN SLOAN-KETTERING INST CAN RESEARCH NY $263,445
Lung Cancer 2018 NCI 2P01CA129243-11 5314 Project 2: Targeting the ERK Pathway in KRAS- and BRAF-Driven Lung Cancers ROSEN, NEAL SLOAN-KETTERING INST CAN RESEARCH NY $286,672
Lung Cancer 2018 NCI 2P01CA129243-11 5315 Project 3: Mechanisms and Modulators of Sensitivity and Resistance to Kinase Inhibitors in Lung Cancer LOVLY, CHRISTINE SLOAN-KETTERING INST CAN RESEARCH NY $294,395
Lung Cancer 2018 NCI 2P01CA129243-11 5316 Project 4: Lung Cancer Drivers and Dependencies as Therapeutic Targets LOWE, SCOTT SLOAN-KETTERING INST CAN RESEARCH NY $284,838
Lung Cancer 2018 NCI 2P01CA129243-11 5317 Administrative Core KRIS, MARK SLOAN-KETTERING INST CAN RESEARCH NY $164,575
Lung Cancer 2018 NCI 2P01CA129243-11 5318 Core 1: Biostatistics and Bioinformatics SHEN, RONGLAI SLOAN-KETTERING INST CAN RESEARCH NY $155,654
Lung Cancer 2018 NCI 2P01CA129243-11 5319 Core 2: Molecular Profiling and Pathology LADANYI, MARC SLOAN-KETTERING INST CAN RESEARCH NY $276,090
Lung Cancer 2018 NCI 5R01CA197422-03 Canadian Fluoroscopy Cohort Study: Lifespan Mortality and Incidence Follow-Up ZABLOTSKA, LYDIA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $669,442
Lung Cancer 2018 NCI 5F32CA206247-02 A Collaborative Reporting Tool For Interpreting Genomic Events In Lung Cancers WAGNER, ALEX WASHINGTON UNIVERSITY MO $63,034
Lung Cancer 2018 NCI 5F30CA214015-02 Development of covalent docking to identify new cysteine-targeted K-Ras inhibitors to address allelic variation in cancer NNADI, CHIMNO UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $36,028
Lung Cancer 2018 NCI 5P30CA044579-27 5841 Molecular Genetics and Epigenetics Program - GEN STUKENBERG, P. TODD UNIVERSITY OF VIRGINIA VA $33,470
Lung Cancer 2018 NCI 5P30CA077598-20 6561 Analytical Biochemistry YEE, DOUGLAS UNIVERSITY OF MINNESOTA MN $165,591
Lung Cancer 2018 NCI 5P30CA077598-20 6562 (Basic Shared Resources) Analytical Biochemistry YEE, DOUGLAS UNIVERSITY OF MINNESOTA MN $120,990
Lung Cancer 2018 NCI 1R01CA221978-01 HTS for discovery of inhibitors of the centrosome-independent mitotic spindle machinery ROTH, MICHAEL UT SOUTHWESTERN MEDICAL CENTER TX $370,575
Lung Cancer 2018 NCI 5R43CA213545-02 A Phase I Clinical Trial: Binary Therapy with DM-CHOC-PEN and WBRT in Adults with Cancer Involving the CNS MORGAN, LEE DEKK-TEC, INC. LA $143,294
Lung Cancer 2018 NCI 5P30CA012197-43 6114 Clinical Research (03) PASCHE, BORIS WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $59,073
Lung Cancer 2018 NCI 5P30CA012197-43 6115 Cancer Prevention and Control (04) PASCHE, BORIS WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $53,835
Lung Cancer 2018 NCI 5R01CA213990-02 Transcriptional Regulation of Immunosuppressive Macrophages by c-Maf in Cancer YAN, JUN UNIVERSITY OF LOUISVILLE KY $352,275
Lung Cancer 2018 NCI 1R01CA222823-01 Resistance and Sensitivity to MET Inhibitors in Lung Cancer JANNE, PASI DANA-FARBER CANCER INST MA $390,403
Lung Cancer 2018 NCI 5F32CA213764-02 The role of neuroendocrine transdifferentiation of pancreatic cancer cells on tumor progression and chemoresistance. MORRISON JOLY, MEGHAN OREGON HEALTH & SCIENCE UNIVERSITY OR $24,327
Lung Cancer 2018 NCI 1UM1CA221939-01 Center for Research to Optimize Precision Lung Cancer Screening in Diverse Populations RITZWOLLER, DEBRA KAISER FOUNDATION RESEARCH INSTITUTE CA $3,139,491
Lung Cancer 2018 NCI 5P30CA046934-30 5076 Lung, Head & Neck Cancers Program THEODORESCU, DAN UNIVERSITY OF COLORADO DENVER CO $106,531
Lung Cancer 2018 NCI 1K08CA222625-01 Therapeutic rescue of the transcriptional repressor Capicua to inhibit lung cancer metastasis OKIMOTO, ROSS UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $177,372
Lung Cancer 2018 NIMHD 5R00MD010468-04 Applying mHealth to Tobacco-related Health Disparities: Enhancing aspects of Resiliency to aid Cessation Efforts VINCI, CHRISTINE H. LEE MOFFITT CANCER CTR & RES INST FL $249,148
Lung Cancer 2018 NCI 1K22CA222669-01 Investigating mechanistic underpinnings and therapeutic potential of selective histone deacetylase and bromodomain inhibition for the treatment of non-small cell lung cancer ADEEGBE, OLAKUNLE H. LEE MOFFITT CANCER CTR & RES INST FL $182,485
Lung Cancer 2018 NCI 5U01CA213359-02 Preclinical development of a DLL3-targeted theranostic for small cell lung cancer POIRIER, JOHN SLOAN-KETTERING INST CAN RESEARCH NY $339,331
Lung Cancer 2018 NCI 1R21CA216504-01A1 Identifying Therapeutic Vulnerabilities of c-MYC-driven Small Cell Lung Cancer OLIVER, TRUDY UNIVERSITY OF UTAH UT $165,300
Lung Cancer 2018 NCI 5R01CA081301-20 Metabolism of Carcinogenic Tobacco-Specific Nitrosamines HECHT, STEPHEN UNIVERSITY OF MINNESOTA MN $507,853
Lung Cancer 2018 NCI 5R01CA193556-03 Near infrared intraoperative molecular imaging of lung adenocarcinoma SINGHAL, SUNIL UNIVERSITY OF PENNSYLVANIA PA $654,295
Lung Cancer 2018 NCI 5R01CA204419-03 Induction of Therapeutic Immunity in the Tumor Microenvironment STORKUS, WALTER UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $345,795
Lung Cancer 2018 NCI 5R01CA183594-05 Mitochondrial acetyl-CoA acetyltransferase 1 promotes the Warburg effect CHEN, JING EMORY UNIVERSITY GA $325,093
Lung Cancer 2018 NCI 5R01CA188341-04 IRS-1 Regulates Inflammatory Cell Recruitment in Lung Cancer HOUGHTON, A FRED HUTCHINSON CANCER RESEARCH CENTER WA $396,096
Lung Cancer 2018 NCI 5R01CA192613-04 Pemetrexed and sildenafil for lung cancer DENT, PAUL VIRGINIA COMMONWEALTH UNIVERSITY VA $313,959
Lung Cancer 2018 NCI 5R01CA178061-04 Statistical Qualification of the Impact of Missing Data in EMA Studies XIE, HUI UNIVERSITY OF ILLINOIS AT CHICAGO IL $286,612
Lung Cancer 2018 NCI 5R01CA193532-03 Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy TESSEMA, MATHEWOS LOVELACE BIOMEDICAL & ENVIRONMENTAL RES NM $581,451
Lung Cancer 2018 NCI 5R01CA202699-03 Testing an Organizational Change Model to Address Smoking in Mental Healthcare SCHNOLL, ROBERT UNIVERSITY OF PENNSYLVANIA PA $653,852
Lung Cancer 2018 NCI 5R01CA175360-05 The role of deubiquitinating enzyme USP33 in Slit-Robo signaling in lung cancer WU, JANE NORTHWESTERN UNIVERSITY AT CHICAGO IL $442,825
Lung Cancer 2018 NCI 5R01CA181449-04 Interrogation of MLL2 as a tumor suppressor gene in lung cancer MACPHERSON, DAVID FRED HUTCHINSON CANCER RESEARCH CENTER WA $402,600
Lung Cancer 2018 NCI 5R01CA177996-05 CYCORE: Cyberinfrastructure for Cancer Comparative Effectiveness Research PATRICK, KEVIN UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $139,970
Lung Cancer 2018 NCI 5F31CA203254-03 Biochemical and Functional Characterization of the Mutagenic Cytidine Deaminase APOBEC3B in the contextof Squamous Cell Lung Carcinoma SASAKI, TOMOAKI YALE UNIVERSITY CT $8,061
Lung Cancer 2018 NCI 5R01CA204020-03 Role of GAS41 in human cancer SHI, XIAOBING UNIVERSITY OF TX MD ANDERSON CAN CTR TX $36,600
Lung Cancer 2018 NCI 5R01CA175316-05 Transcription-dependent and -independent signaling of RSK2 in cancer metastasis KANG, SUMIN EMORY UNIVERSITY GA $323,700
Lung Cancer 2018 NCI 5R01CA174786-05 Signaling and Targeting of 6-Phosphogluconate Dehydrogenase in Human Cancers CHEN, JING EMORY UNIVERSITY GA $325,412
Lung Cancer 2018 NCI 5U24CA213274-02 Coordinating center for the NCI small cell lung cancer research consortium RUDIN, CHARLES SLOAN-KETTERING INST CAN RESEARCH NY $1,089,718
Lung Cancer 2018 NCI 1R01CA223804-01 Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer YOU, MING MEDICAL COLLEGE OF WISCONSIN WI $653,885
Lung Cancer 2018 NCI 1R21CA223335-01 Targeted proteomics to aid in the management of patients with stage IA lung adeno BORGIA, JEFFREY RUSH UNIVERSITY MEDICAL CENTER IL $170,738
Lung Cancer 2018 NCI 5F31CA213744-02 Mechanistic Insights into ALK Fusion Biology Through Investigation of the Fusion Partner CHILDRESS, MERRIDA VANDERBILT UNIVERSITY TN $17,026
Lung Cancer 2018 NCI 5F32CA213898-02 KLF6: A driving factor of lung adenocarcinoma MCKENNA, BRIAN UNIVERSITY OF VIRGINIA VA $28,641
Lung Cancer 2018 NCI 5R01CA121249-09 Cachexia in ApcMin/+ mice: The role of IL-6 CARSON, JAMES UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA SC $243,653
Lung Cancer 2018 NCI 5R01CA105155-14 Regulation of Lung Cancer Metastasis by a Procollagen Lysine Hydroxylase KURIE, JONATHAN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $306,476
Lung Cancer 2018 NCI 5U10CA180795-05 Building upon a tradition of excellence. The NCTN at Indiana University MILLER, KATHY INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $562,579
Lung Cancer 2018 NCI 5F30CA196103-04 MicroRNAs mediating Notch signaling in lung adenocarcinoma MORGAN, KATHERINE RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL NJ $49,524
Lung Cancer 2018 NCI 5R01CA203964-03 Highly multiplexed and mutation-sensitive quantitative PCR for cancer diagnostics ZHANG, DAVID RICE UNIVERSITY TX $612,394
Lung Cancer 2018 NCI 5U10CA180816-05 Stanford University NCTN- Network Lead Academic Site WAKELEE, HEATHER STANFORD UNIVERSITY CA $518,824
Lung Cancer 2018 NCI 5K99CA215244-02 Investigating the role of KLF5 genomic alterations in tumorigenesis ZHANG, XIAOYANG DANA-FARBER CANCER INST MA $133,704
Lung Cancer 2018 NIBIB 1R15EB024283-01A1 Fast and Robust Low-Dose X-Ray CT Image Reconstruction ZENG, LARRY WEBER STATE UNIVERSITY UT $273,846
Lung Cancer 2018 NCI 5U10CA180950-05 ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center RAMALINGAM, SURESH EMORY UNIVERSITY GA $569,732
Lung Cancer 2018 NCI 1R03CA223619-01 Predicted lean body mass, fat mass, and risk of lung, pancreatic, colorectal, breast, and prostate cancers GIOVANNUCCI, EDWARD HARVARD SCHOOL OF PUBLIC HEALTH MA $79,750
Lung Cancer 2018 NCI 1R03CA223637-01 The hexosamine biosynthesis pathway in human bronchial epithelial cell transformation. CHEN, WENSHU LOVELACE BIOMEDICAL & ENVIRONMENTAL RES NM $109,000
Lung Cancer 2018 NCI 5U01CA199240-02 Detroit Research on Cancer Survivors (Detroit ROCS) SCHWARTZ, ANN WAYNE STATE UNIVERSITY MI $1,995,543
Lung Cancer 2018 NCI 5R35CA197605-03 Mucins and immune cell interactions in ovarian cancer pathogenesis & progression CRAMER, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $966,086
Lung Cancer 2018 NCI 5R01CA204302-02 Characterization of YAP as a rational companion target in lung cancer BIVONA, TREVER UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $362,569
Lung Cancer 2018 NCI 5F30CA206339-03 EGFR rearrangements as oncogenic drivers and therapeutic targets in lung cancer GALLANT, JEAN-NICOLAS VANDERBILT UNIVERSITY TN $44,524
Lung Cancer 2018 NCI 5R01CA193396-03 Implementing Cancer Prevention Using Patient - Provider Clinical Decision Support ELLIOTT, THOMAS HEALTHPARTNERS INSTITUTE MN $607,365
Lung Cancer 2018 NCI 5R01CA208648-02 Chemoprevention of lung cancer with mitochondria-targeted honokiol YOU, MING MEDICAL COLLEGE OF WISCONSIN WI $627,013
Lung Cancer 2018 NCI 5R01CA185169-05 Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics MCKNIGHT, STEVEN UT SOUTHWESTERN MEDICAL CENTER TX $475,351
Lung Cancer 2018 NCI 5R01CA176568-05 Epigenetic miRNA, SNP Signatures, and their Functions in Lung Cancer Outcomes GU, JIAN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $494,883
Lung Cancer 2018 NCI 5R03CA215941-02 p53 mutation induces constitutive expression of interferon beta, enhancing the resistance of cancer cells to DNA damage CHEON, HYEONJOO CLEVELAND CLINIC LERNER COM-CWRU OH $79,250
Lung Cancer 2018 NCI 1R01CA214948-01A1 Targeting Metabolic Liabilities in Cancer POSSEMATO, RICHARD NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $390,657
Lung Cancer 2018 NCI 5R01CA177852-04 INHIBITION OF A TREG DEUBIQUITINASE, USP7, PROMOTES ANTI-TUMOR IMMUNITY HANCOCK, WAYNE CHILDREN'S HOSP OF PHILADELPHIA PA $380,640
Lung Cancer 2018 NCI 5F30CA216891-02 Investigating the role of EphA2 receptor tyrosine kinase in anti-tumor immunity mediated through programmed cell death ligand 2 (PD-L2) in non-small cell lung cancer (NSCLC) SHIUAN, EILEEN VANDERBILT UNIVERSITY TN $29,198
Lung Cancer 2018 NCI 5R01CA169259-06 Overcoming resistance to tyrosine kinase inhibitors in lung cancer KOBAYASHI, SUSUMU BETH ISRAEL DEACONESS MEDICAL CENTER MA $361,049
Lung Cancer 2018 NCI 5R01CA193698-04 Role of the mitochondrial citrate carrier SLC25A1(CIC)in cancer progression and therapy AVANTAGGIATI, MARIA GEORGETOWN UNIVERSITY DC $355,706
Lung Cancer 2018 NCI 1R37CA214609-01A1 The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer GIBBONS, DON UNIVERSITY OF TX MD ANDERSON CAN CTR TX $366,000
Lung Cancer 2018 NCI 1R01CA215188-01A1 Randomized Trial of Stepped Palliative Care versus Early Integrated Palliative Care in Patients with Advanced Lung Cancer TEMEL, JENNIFER MASSACHUSETTS GENERAL HOSPITAL MA $523,338
Lung Cancer 2018 NCI 2R01CA095039-10A1 Smoking-Induced Epigenetic Changes in the Lung: Role of DNA Demethylation TRETYAKOVA, NATALIA UNIVERSITY OF MINNESOTA MN $345,873
Lung Cancer 2018 NCI 5R01CA192399-04 Identifying tumor suppressor targets of SIRT6 in lung cancer MAYO, MARTY UNIVERSITY OF VIRGINIA VA $393,711
Lung Cancer 2018 NCI 5K07CA197221-03 Designing a Comprehensive Framework for the Evaluation of Tobacco Product Risks BERMAN, MICAH OHIO STATE UNIVERSITY OH $165,290
Lung Cancer 2018 NCI 5R01CA204620-03 Molecular Dissection of an Arntl2 induced pro-metastatic secretome WINSLOW, MONTE STANFORD UNIVERSITY CA $367,403
Lung Cancer 2018 NCI 1R01CA214427-01A1 Implementing A Virtual Tobacco Treatment in Community Oncology Practices PARK, ELYSE MASSACHUSETTS GENERAL HOSPITAL MA $759,089
Lung Cancer 2018 NCI 1R01CA215240-01A1 Lung Screening: Efficacy versus Effectiveness GAREEN, ILANA BROWN UNIVERSITY RI $532,539
Lung Cancer 2018 NCI 1R01CA212411-01A1 Exploiting KRAS addiction for lung cancer therapy CHERESH, DAVID UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $413,109
Lung Cancer 2018 NCI 5UH2CA206126-02 Advancing EFIRM-Liquid Biopsy (eLB) to a CLIA-Certified Laboratory Developed Test (eLB-LDT) for Detection of Actionable EGFR Mutations in NSCLC Patients WONG, DAVID UNIVERSITY OF CALIFORNIA LOS ANGELES CA $184,223
Lung Cancer 2018 NCI 2R01CA151433-06A1 Multimodal Image-Guided Intervention System for Lung-Cancer Diagnosis and Staging HIGGINS, WILLIAM PENNSYLVANIA STATE UNIVERSITY-UNIV PARK PA $392,552
Lung Cancer 2018 NCI 1R01CA217169-01A1 BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma JONES, DAVID SLOAN-KETTERING INST CAN RESEARCH NY $414,944
Lung Cancer 2018 NCI 2U01CA167462-06 Infrastructure Support and Pilot Tissue Collection for the CARET Biorepository CHEN, CHU FRED HUTCHINSON CANCER RESEARCH CENTER WA $564,986
Lung Cancer 2018 NCI 5R01CA206155-03 Crosstalk of LKB1 and KEAP1 mutations in driving growth of lung adenocarcinoma BISWAL, SHYAM JOHNS HOPKINS UNIVERSITY MD $395,755
Lung Cancer 2018 NCI 5R01CA207483-02 Markerless Motion Tracking of Lung Tumors Using Dual Energy Imaging ROESKE, JOHN LOYOLA UNIVERSITY CHICAGO IL $299,052
Lung Cancer 2018 NCI 5R01CA207763-02 The role of PCDH7 in lung cancer pathogenesis O'DONNELL, KATHRYN UT SOUTHWESTERN MEDICAL CENTER TX $357,482
Lung Cancer 2018 NCI 5R01CA203928-02 Targeted inhibition of ribosomal RNA synthesis in LKB1-deficient cancers ZHOU, WEI EMORY UNIVERSITY GA $356,850
Lung Cancer 2018 NCI 5R33CA202867-03 High Throughput GO Chip isolation of Lung CTCs for Molecular Diagnosis and Drug Testing NAGRATH, SUNITHA UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $333,698
Lung Cancer 2018 NCI 5R01CA206028-03 (PQ9) Mitigation of chemotherapy induced peripheral neuropathy GEWIRTZ, DAVID VIRGINIA COMMONWEALTH UNIVERSITY VA $342,846
Lung Cancer 2018 NCI 5R01CA186729-04 Differential regulation of RNA processing by Akt isoforms TSICHLIS, PHILIP TUFTS MEDICAL CENTER MA $377,438
Lung Cancer 2018 NCI 5R01CA188743-04 Differential MRI imaging for brain tumor metastases diagnosis and treatment monitoring LJUBIMOVA, JULIA CEDARS-SINAI MEDICAL CENTER CA $497,850
Lung Cancer 2018 NCI 5R21CA216650-02 Sphingosine-1-phosphate receptor subtype 3 in oncogenic K-Ras mutant-driven lung adenocarcinoma LEE, MENQ-JER WAYNE STATE UNIVERSITY MI $215,985
Lung Cancer 2018 NIBIB 5R01EB022596-02 Nanoscintillator-based X-ray sensitizers to enable efficient NSCLC treatment with X-ray irradiation XIE, JIN UNIVERSITY OF GEORGIA GA $476,715
Lung Cancer 2018 NCI 1K07CA215546-01A1 Electronic cigarette use in lung cancer patients BRASKY, THEODORE OHIO STATE UNIVERSITY OH $138,887
Lung Cancer 2018 NCI 1K99CA215316-01A1 New mechanisms of acquired resistance to EGFR-TKIs in Non-small-cell lung cancer HE, JUN THOMAS JEFFERSON UNIVERSITY PA $98,086
Lung Cancer 2018 NIEHS 5R01ES014032-09 Cancer in adults following in utero and early life exposure to arsenic STEINMAUS, CRAIG UNIVERSITY OF CALIFORNIA BERKELEY CA $442,424
Lung Cancer 2018 NCI 5R01CA148805-08 Role of STE20 protein kinases in malignant mesothelioma CHERNOFF, JONATHAN RESEARCH INST OF FOX CHASE CAN CTR PA $434,625
Lung Cancer 2018 NCI 5K99CA215249-02 Mapping druggable co-dependency pathways in NRF2-driven lung cancers BAR-PELED, LIRON SCRIPPS RESEARCH INSTITUTE CA $114,750
Lung Cancer 2018 NIBIB 5R01EB022558-03 Targeting Solid Tumors Using Nano-Engineered MSCs PRABHA, SWAYAM UNIVERSITY OF MINNESOTA MN $330,981
Lung Cancer 2018 NCI 5R01CA156744-08 The role of FBXW2 as a novel lung tumor suppressor that cross-talks with oncogenic beta-TrCP and SKP2 SUN, YI UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $368,125
Lung Cancer 2018 NCI 1R21CA216066-01A1 Extracellular matrix regulation of lung adenocarcinoma signaling and drug responsiveness UNDERHILL, GREGORY UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $211,797
Lung Cancer 2018 NCI 5F30CA213817-02 Targeting lung and breast cancer cell oxidative metabolism with D-penicillamine and disulfiram FALLS, KELLY UNIVERSITY OF IOWA IA $34,592
Lung Cancer 2018 NCI 5R01CA164273-07 Identification of Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors SHAW, ALICE MASSACHUSETTS GENERAL HOSPITAL MA $399,380
Lung Cancer 2018 NCI 5U01CA186157-04 Hybrid Plasma Markers that Complement CT Imaging for Early Lung Cancer Detection LAMPE, PAUL FRED HUTCHINSON CANCER RESEARCH CENTER WA $481,475
Lung Cancer 2018 NCI 5R01CA197928-03 Small-Molecule Antagonists of Ral GTPases in Cancer MEROUEH, SAMY INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $586,717
Lung Cancer 2018 NCI 5R01CA205150-03 Therapeutic approaches for LKB1-deficient non-small cell lung cancer HEYMACH, JOHN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $605,252
Lung Cancer 2018 NCI 5R01CA204222-02 Outcomes associated with significant incidental findings in lung cancer screening GAREEN, ILANA BROWN UNIVERSITY RI $317,576
Lung Cancer 2018 NCI 1R01CA216051-01A1 The Role of Protein Kinases in NRF2-driven Lung Squamous Cell Carcinoma WEISSMAN, BERNARD UNIV OF NORTH CAROLINA CHAPEL HILL NC $500,167
Lung Cancer 2018 NCI 1U01CA224326-01 Studies of the initiation and progression of small cell lung cancer using cells derived by differentiation from human pluripotent stem cells VARMUS, HAROLD WEILL MEDICAL COLL OF CORNELL UNIV NY $462,937
Lung Cancer 2018 NCI 5F31CA216915-02 Understanding the consequences of oncogenic mutations on FGFR signaling RYAN, MOLLY YALE UNIVERSITY CT $44,524
Lung Cancer 2018 NCI 5R01CA197486-03 Circulating DNA as a Marker of Treatment Efficacy and Failure in Lung Cancer PATEL, ABHIJIT YALE UNIVERSITY CT $383,156
Lung Cancer 2018 NCI 5P01CA200512-03 8131 Natural History of Cigarette Smoking and Vaporized Nicotine Product Use in Countries with Different Policy Environments FONG, GEOFFREY UNIVERSITY OF WATERLOO CANADA $819,944
Lung Cancer 2018 NCI 5P01CA200512-03 8132 Nicotine and Cigarettes Across Policy Environments O'CONNOR, RICHARD ROSWELL PARK CANCER INSTITUTE CORP NY $463,467
Lung Cancer 2018 NCI 5P01CA200512-03 8133 Vaporized Nicotine Product Initiation Among Youth in the US, Canada, and England: Methods to Predict Uptake and Policy Efficacy HAMMOND, DAVID UNIVERSITY OF WATERLOO CANADA $237,722
Lung Cancer 2018 NCI 5P01CA200512-03 8134 The Experimental Tobacco Marketplace (ETM) BICKEL, WARREN NIH $359,289
Lung Cancer 2018 NCI 5P01CA200512-03 8135 Modeling Industry Behavior and the Use of Vaporized Nicotine Products on Population Health LEVY, DAVID GEORGETOWN UNIVERSITY DC $186,641
Lung Cancer 2018 NCI 5U01CA213330-02 Extracellular Vesicles in Small Cell Lung Cancer Early Detection NANA-SINKAM, SERGE VIRGINIA COMMONWEALTH UNIVERSITY VA $593,585
Lung Cancer 2018 NCI 5R01CA137008-09 Impact of heterogeneity on response to EGFR T790M inhibitors SEQUIST, LECIA MASSACHUSETTS GENERAL HOSPITAL MA $406,220
Lung Cancer 2018 NCI 5R01CA116020-12 Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma ECK, MICHAEL DANA-FARBER CANCER INST MA $374,063
Lung Cancer 2018 NCI 5R01CA190722-04 Targeting Anaphase Catastrophe to Combat Lung Cancer KURIE, JONATHAN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $366,425
Lung Cancer 2018 NCI 5R01CA201513-03 Notch signaling in small cell lung carcinoma SAGE, JULIEN STANFORD UNIVERSITY CA $372,322
Lung Cancer 2018 NCI 5R01CA207288-02 Development of SHP2 inhibitors for targeted anti-cancer therapy ZHANG, ZHONG-YIN PURDUE UNIVERSITY IN $469,466
Lung Cancer 2018 NCI 5R33CA202822-03 Bioengineered Lung Tumor Organoids For Development Of Personalized Medicine SOKER, SHAY WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $385,924
Lung Cancer 2018 NIDA 5R01DA035796-05 Advancing Tobacco Use Treatment for African American Smokers COX, LISA UNIVERSITY OF KANSAS MEDICAL CENTER KS $625,623
Lung Cancer 2018 NIDCR 5R01DE026013-03 Deposition Profile and Toxicology of E-Cigarettes in the Oral Epithelium BELINSKY, STEVEN LOVELACE BIOMEDICAL & ENVIRONMENTAL RES NM $545,000
Lung Cancer 2018 NCI 5F32CA210516-02 Mechanisms of Response and Resistance to Immune Checkpoint Inhibitors in Lung Adenocarcinoma HASTINGS, KATHERINE YALE UNIVERSITY CT $59,038
Lung Cancer 2018 NCI 5R01CA193473-03 Integrative systems approach to identify local oncogenic modulation of the IL12 axis KLINKE, DAVID WEST VIRGINIA UNIVERSITY WV $343,125
Lung Cancer 2018 NCI 5R01CA205165-02 Mechanisms that control the progression from premalignant lesions to adenocarcinomas in the lung GALBIATI, FERRUCCIO UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $312,500
Lung Cancer 2018 NCI 5P30CA086862-18 7673 Program 4: Cancer Epidemiology and Population Science LYNCH, CHARLES UNIVERSITY OF IOWA IA $30,038
Lung Cancer 2018 NCI 5U24CA115091-13 University of Maryland, Baltimore Biomarker Reference Laboratory STASS, SANFORD UNIVERSITY OF MARYLAND BALTIMORE MD $575,204
Lung Cancer 2018 NCI 5R01CA194663-04 (PQC1) Accelerated biological aging and colon polyp to cancer progression GRADY, WILLIAM FRED HUTCHINSON CANCER RESEARCH CENTER WA $401,448
Lung Cancer 2018 NCI 5U01CA200495-03 Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer SHOWE, LOUISE WISTAR INSTITUTE PA $786,485
Lung Cancer 2018 NCI 5R01CA139067-07 miR-200 miRNAs repress tumor metastasis in lung adenocarcinoma HE, LIN UNIVERSITY OF CALIFORNIA BERKELEY CA $373,266
Lung Cancer 2018 NIGMS 5R01GM100387-06 Transfer Rule Learning with Functional Mapping for Integrative Modeling of Panomics Data GOPALAKRISHNAN, VANATHI UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $292,354
Lung Cancer 2018 NCATS 2R44TR001286-02 Tools for drug efficacy studies in perfused tissue models VUKASINOVIC, JELENA LENA BIOSCIENCES, INC. GA $724,224
Lung Cancer 2018 NCI 5U10CA180868-05 NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER WOLMARK, NORMAN NRG ONCOLOGY FOUNDATION, INC. PA $12,282,049
Lung Cancer 2018 NCI 5R35CA197452-04 Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma FLORES, ELSA H. LEE MOFFITT CANCER CTR & RES INST FL $904,242
Lung Cancer 2018 NCI 5U01CA152662-08 Validation of Biomarkers of Risk for the Early Detection of Lung Cancer MASSION, PIERRE VANDERBILT UNIVERSITY MEDICAL CENTER TN $711,290
Lung Cancer 2018 NCI 5R01CA197936-03 Determinants of acquired resistance in small cell lung cancer RUDIN, CHARLES SLOAN-KETTERING INST CAN RESEARCH NY $619,653
Lung Cancer 2018 NHLBI 5R01HL131907-03 PET Imaging of Pulmonary Fibrosis CARAVAN, PETER MASSACHUSETTS GENERAL HOSPITAL MA $752,479
Lung Cancer 2018 NCI 2R44CA203058-02A1 A Computer Tool for Aiding in Accurate Assessment of Indeterminate Lung Nodules MENG, XIN INTERNATIONAL INTELLIGENT INFOR/SOLU/LAB PA $529,613
Lung Cancer 2018 NCI 1R01CA224493-01 Tumor-selective radiosensitization of NSCLC using NQO1 bioactivatable drugs BOOTHMAN, DAVID INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $347,128
Lung Cancer 2018 NCI 5R44CA188154-03 Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research PREMSRIRUT, PREM MIRIMUS, INC. NY $751,587
Lung Cancer 2018 NCI 1F31CA224960-01 Investigation of an ABL kinase-dependent signaling axis required for lung cancer brain metastasis HOJ, JACOB DUKE UNIVERSITY NC $44,524
Lung Cancer 2018 NCI 5R21CA208206-02 Exposure to flavored tobacco advertising and associations with future use in young adults: implications for health equity ROSE, SHYANIKA TRUTH INITIATIVE FOUNDATION DC $150,556
Lung Cancer 2018 NCI 1F31CA225119-01 Elucidating and Targeting EZH2 in the DNA Damage Response in Small Cell Lung Cancer KOYEN, ALLYSON EMORY UNIVERSITY GA $44,524
Lung Cancer 2018 NCI 1R01CA218357-01A1 Bronchoscope-guided microwave ablation of early-stage lung tumors PRAKASH, PUNIT KANSAS STATE UNIVERSITY KS $321,353
Lung Cancer 2018 NCI 1R01CA216579-01A1 Computerized Histologic Risk Predictor (CHiRP) for Early Stage Lung Cancers MADABHUSHI, ANANT CASE WESTERN RESERVE UNIVERSITY OH $670,734
Lung Cancer 2018 NCI 1R01CA217841-01A1 A Multimedia Self-Management Intervention to Prepare Family Caregivers and Patients for Lung Cancer Surgery SUN, VIRGINIA BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $717,367
Lung Cancer 2018 NCI 5R01CA203193-03 Comparative Effectiveness of Limited Resection vs. Stereotactic Body Radiation Therapy for Early Stage Lung Cancer WISNIVESKY, JUAN ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $646,326
Lung Cancer 2018 NIEHS 1R01ES028600-01A1 Benzo[a]pyrene Micro-dosing of Humans: A New Tool for Exposure, Risk Assessment and Prevention WILLIAMS, DAVID OREGON STATE UNIVERSITY OR $580,890
Lung Cancer 2018 NCI 5R01CA210806-02 Optimizing Lung Cancer Treatment in HIV Infected Persons SIGEL, KEITH ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $551,979
Lung Cancer 2018 NCI 1R01CA217165-01A1 Retail Environment for Tobacco and Marijuana in California: Impact on College Student Use HENRIKSEN, LISA STANFORD UNIVERSITY CA $664,248
Lung Cancer 2018 NIEHS 1R01ES028072-01A1 Regulation of p53 and Checkpoint Signaling by Chromium(VI) ZHITKOVICH, ANATOLY BROWN UNIVERSITY RI $365,625
Lung Cancer 2018 NIEHS 1R01ES027901-01A1 Chromium in carcinogenesis and angiogenesis JIANG, BINGHUA UNIVERSITY OF IOWA IA $320,890
Lung Cancer 2018 NCI 1UG3CA225021-01 Methods and Tools for Integrating Pathomics Data into Cancer Registries SALTZ, JOEL STATE UNIVERSITY NEW YORK STONY BROOK NY $430,543
Lung Cancer 2018 NCI 5R01CA163591-07 Tumor Cell Dependence on Host Metabolism WHITE, EILEEN RUTGERS, THE STATE UNIV OF N.J. NJ $444,948
Lung Cancer 2018 NIEHS 5R21ES028006-02 Exosomes in Environmental Tobacco Smoke-induced Lung Cellular Senescence RAHMAN, IRFAN UNIVERSITY OF ROCHESTER NY $192,500
Lung Cancer 2018 NIEHS 5R01ES021771-05 Apoptosis resistance and Cr(VI) carcinogenesis ZHANG, ZHUO UNIVERSITY OF KENTUCKY KY $338,625
Lung Cancer 2018 NHLBI 5R01HL109031-07 Enhancing the Effectiveness of Varenicline Based Smoking Cessation Treatment BAKER, TIMOTHY UNIVERSITY OF WISCONSIN-MADISON WI $1,946,705
Lung Cancer 2018 NIEHS 5R21ES026996-02 Air Quality, Child, and Adult Health in Homes where Hookahs are Smoked WEITZMAN, MICHAEL NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $254,250
Lung Cancer 2018 NHLBI 5R01HL105397-08 Genetic Association and Personalized Medicine PAN, WEI UNIVERSITY OF MINNESOTA MN $372,063
Lung Cancer 2018 NCI 1U54CA217450-01A1 8867 Modeling the SCLC Phenotypic Space QUARANTA, VITO VANDERBILT UNIVERSITY TN $564,861
Lung Cancer 2018 NCI 1U54CA217450-01A1 8868 Phenotype Interactions and Dynamics in SCLC Tumors WEAVER, ALISSA VANDERBILT UNIVERSITY TN $464,274
Lung Cancer 2018 NCI 5R01CA209818-02 Tumor-targeted nanoparticle-based delivery system for imaging and treatment of cancer MINKO, TAMARA RUTGERS, THE STATE UNIV OF N.J. NJ $463,244
Lung Cancer 2018 NCI 5R01CA193935-03 The role of EGFR as a mechanism of therapeutic resistance in gene fusion positive lung cancer. DOEBELE, ROBERT UNIVERSITY OF COLORADO DENVER CO $422,586
Lung Cancer 2018 NCI 5R01CA190542-04 RIP1/3 Kinases as New Targets in Malignant Mesothelioma TESTA, JOSEPH RESEARCH INST OF FOX CHASE CAN CTR PA $423,359
Lung Cancer 2018 NCI 5R01CA174768-05 Understanding optimal delivery systems for cancer care MILLER, DAVID UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $380,646
Lung Cancer 2018 NCI 5K07CA188142-04 Evaluating a Risk Prediction Model for Lung Cancer SAKODA, LORI KAISER FOUNDATION RESEARCH INSTITUTE CA $192,864
Lung Cancer 2018 NCI 5R01CA190610-04 Detoxication of Air Pollutants in Humans with a Broccoli Supplement GROOPMAN, JOHN JOHNS HOPKINS UNIVERSITY MD $421,934
Lung Cancer 2018 NCI 5R01CA195549-04 Novel target for therapy refractory lung tumors PENDERGAST, ANN MARIE DUKE UNIVERSITY NC $359,887
Lung Cancer 2018 NCI 5R33CA202811-03 Development and Validation of a Microdissection Method to Advance Precision Medicine in the Clinical Setting JOHANN, DONALD UNIV OF ARKANSAS FOR MED SCIS AR $385,890
Lung Cancer 2018 NCI 5R01CA197329-04 Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors GRAY, NATHANAEL DANA-FARBER CANCER INST MA $540,936
Lung Cancer 2018 NCI 5R01CA184624-05 elF4E-Dependent Translation Control in the Oncogenic Stress Response and Cancer RUGGERO, DAVIDE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $359,006
Lung Cancer 2018 NIEHS 5R01ES024050-05 Recognition of Environmental Carcinogen-DNA lesions by NER Proteins GEACINTOV, NICHOLAS NEW YORK UNIVERSITY NY $353,227
Lung Cancer 2018 NCI 5R01CA198121-03 Dose-distribution radiomics to predict morbidity risk in radiotherapy DEASY, JOSEPH SLOAN-KETTERING INST CAN RESEARCH NY $577,261
Lung Cancer 2018 NCI 5R01CA204070-04 Lung cancer in never smokers: incidence, risk factors, and molecular characteristics in Asian American, Native Hawaiian and Pacific Islanderfemales GOMEZ, SCARLETT UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $675,424
Lung Cancer 2018 NCI 5R01CA206540-03 Molecular and cellular mechanisms of SCLC metastasis SAGE, JULIEN STANFORD UNIVERSITY CA $409,796
Lung Cancer 2018 NCI 5K24CA201543-03 Development of New Cancer Treatments and Investigators GERBER, DAVID UT SOUTHWESTERN MEDICAL CENTER TX $168,058
Lung Cancer 2018 NCI 5P30CA023100-32 6334 Cancer Prevention LIPPMAN, SCOTT UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $22,069
Lung Cancer 2018 NCI 5R01CA193278-05 Dihydromethysticin (DHM) for Lung Cancer Chemoprevention XING, CHENGGUO UNIVERSITY OF FLORIDA FL $315,944
Lung Cancer 2018 NCI 5P30CA138292-10 8759 Cancer Prevention and Control LASH, TIMOTHY EMORY UNIVERSITY GA $82,644
Lung Cancer 2018 NCI 1U01CA225431-01 Integrating Radiomics into S0819 and Lung-MAP, Biomarker Driven Clinical Trials for Lung Cancer SCHWARTZ, LAWRENCE COLUMBIA UNIVERSITY HEALTH SCIENCES NY $644,727
12345


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer
Page Last Updated on July 8, 2015
This site is best viewed with Internet Explorer (7.0 or higher) or Mozilla Firefox (3.0).

NIH...Turning Discovery Into Health®